Hangzhou Tigermed Consulting Co., Ltd
300347
Rankning i aktier
#3217
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides... Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People’s Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting services directly related to clinical trials, including clinical operation, clinical trials, and clinical trials management. It also provides clinical trial related and laboratory services in the drug development process comprising data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, and laboratory services. In addition, the company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. Further, it provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People’s Republic of China.
Aktiekurs
$7.44
Marknadsvärde
$5.49B
Förändring (1 dag)
-2.99%
Förändring (1 år)
-0.42%
Land
CN
Handel Hangzhou Tigermed Consulting Co., Ltd (300347)
Kategori
Healthcare
Intäkter för Hangzhou Tigermed Consulting Co., Ltd (300347)
Intäkter i Jun 2026 TTM: $1.09B
Enligt Hangzhou Tigermed Consulting Co., Ltd senaste finansiella rapporter är företagets nuvarande intäkter (TTM) $1.09B. År 2024 hade företaget intäkter på $904.65M en minskning jämfört med intäkterna år 2023, som var $1.04B. Intäkter är det totala belopp som ett företag genererar från försäljning av varor eller tjänster. Till skillnad från vinst dras inga kostnader av.
Intäktshistorik för Hangzhou Tigermed Consulting Co., Ltd från 2009 till 2026
Intäkter vid slutet av varje år
| År | Intäkter | Ändra |
|---|---|---|
| 2026 (TTM) | $1.09B | 11.78% |
| 2025 | $976.62M | 7.96% |
| 2024 | $904.65M | -13.28% |
| 2023 | $1.04B | 27.17% |
| 2022 | $820.27M | 67.86% |
| 2020 | $488.66M | 21.38% |
| 2019 | $402.58M | 20.37% |
| 2018 | $334.47M | 28.99% |
| 2017 | $259.30M | 53.27% |
| 2016 | $169.17M | 14.79% |
| 2015 | $147.37M | 46.15% |
| 2014 | $100.83M | 81.75% |
| 2013 | $55.48M | 36.03% |
| 2012 | $40.78M | 33.03% |
| 2011 | $30.66M | 64.72% |
| 2010 | $18.61M | 102.35% |
| 2009 | $9.20M | 0.00% |
Intäkter för liknande företag eller konkurrenter
| Företag | Intäkter | Intäktsdifferens | Land |
|---|---|---|---|
| $12.62B | 1,056.47% |
US
|
|
| $2.23B | 104.10% |
US
|
|
| $15.74B | 1,342.29% |
AU
|
|
| $9.57B | 776.91% |
BE
|
|
| $6.02B | 451.59% |
NL
|
